These results reinforce the hypothesis that sEVs are critical for the TGF-β signaling hyperactivation in highly-metastatic cancer cells but have minor relevance for near-normal TGF-β signaling levels in poorly-metastatic cells. This evidence concerns the gene TGFB1 and cancer.